A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2001
11/06/2001	US6312695 Isolated polypeptide with given sequence
11/06/2001	US6312693 Antibodies against human CD40
11/06/2001	US6312692 Method of treating graft-versus-host disease with anti-GP39 antibodies and bone marrow cells
11/06/2001	US6312691 Treating tumors
11/06/2001	US6312690 Monoclonal recombinant anti-rhesus D (D7C2) antibody
11/06/2001	US6312688 Tyrosine-phosphatase-related protein
11/06/2001	US6312684 Antitumor agents
11/06/2001	US6312681 Compositions and methods for the treatment of cancer using recombinant viral vector delivery systems
11/06/2001	US6312665 Aerosol formulations for buccal and pulmonary application
11/06/2001	US6312663 Prediction of diabetes impaired wound healing by urinary nitrate assay
11/06/2001	US6312602 Casein, blood albumin, beef peptone, nucleic acid (rna) and a base such as sodium hydroxide; stimulates phagocytic activity of neutrophils
11/06/2001	CA2250251C Pharmaceutical compositions of botulinum toxin or botulinum neurotoxin and methods of preparation
11/06/2001	CA2032559C Endothelin antagonistic cyclic pentapeptides
11/01/2001	WO2001081928A1 Diagnostic assay and method of treatment involving macrophage inhibitory cytokine -1 (mic-1)
11/01/2001	WO2001081918A1 Transcriptionally regulated g protein-coupled receptor g2a
11/01/2001	WO2001081629A1 Diagnostic and therapeutic methods using the h37 tumor suppressor gene
11/01/2001	WO2001081599A2 Protection against environmental toxicity through manipulation of the processing of messenger rna precursors
11/01/2001	WO2001081595A2 Human caspase-14 compositions
11/01/2001	WO2001081594A1 A novel polypeptide, a human pax protein 17 and the polynucleotide encoding the polypeptide
11/01/2001	WO2001081592A1 A novel polypeptide, a human protein 11 containing signalase i characteristic sequence fragment and the polynucleotide encoding the polypeptide
11/01/2001	WO2001081590A2 Protein phosphatases
11/01/2001	WO2001081588A2 2246, novel protein kinase molecules and uses therefor
11/01/2001	WO2001081587A1 Acetyltransferase and uses thereof
11/01/2001	WO2001081585A2 A thymus expressed human cytochrome p450 (p450tec)
11/01/2001	WO2001081578A2 Novel proteins and nucleic acids encoding same
11/01/2001	WO2001081577A2 Dna encoding the prost 03 polypeptide
11/01/2001	WO2001081576A2 Novel g protein-coupled receptor con-218
11/01/2001	WO2001081573A1 Edg8 receptor, its preparation and use
11/01/2001	WO2001081572A1 A novel polypeptide, a human renal cancer rage4 antigen 25 and the polynucleotide encoding the polypeptide
11/01/2001	WO2001081571A1 A novel polypeptide, a human protein 11 containing g protein coupling receptor conserved region and the polynucleotide encoding the polypeptide
11/01/2001	WO2001081570A2 Heteromultimeric ion channel receptor and uses thereof
11/01/2001	WO2001081569A2 Heparanase ii, a human heparanase paralog
11/01/2001	WO2001081562A1 Novel insulin/igf/relaxin family polypeptides and dnas thereof
11/01/2001	WO2001081559A2 26335, a novel human serine/threonine dehydratase and uses thereof
11/01/2001	WO2001081558A2 13295 novel protein kinase molecules and uses therefor
11/01/2001	WO2001081555A2 Human kinases
11/01/2001	WO2001081554A1 Pneumovirus ns proteins antagonising the interferon (ifn) response
11/01/2001	WO2001081545A2 Regulation of gene expression by hspbp1
11/01/2001	WO2001081544A2 Identification and uses of a hyaluronan receptor
11/01/2001	WO2001081540A2 Growth factor which acts through erb b-4 rtk
11/01/2001	WO2001081538A2 A novel polypeptide, a human connexin 9 and the polynucleotide encoding the polypeptide
11/01/2001	WO2001081536A2 A novel polypeptide, a human ysk1 kinase protein 10, and the polynucleotide encoding the polypeptide
11/01/2001	WO2001081535A2 A novel polypeptide, a human pax protein 9.9 and the polynucleotide encoding the polypeptide
11/01/2001	WO2001081420A1 A novel polypeptide, a laminin 19 and the polynucleotide encoding the polypeptide
11/01/2001	WO2001081419A1 A novel polypeptide, a human beta-globulin control factor 10 and the polynucleotide encoding the polypeptide
11/01/2001	WO2001081417A2 Use of taci as an anti-tumor agent
11/01/2001	WO2001081415A2 Parathyroid hormone and parathyroid hormone-related protein antagonists
11/01/2001	WO2001081414A2 Integrin alpha subunit and uses thereof
11/01/2001	WO2001081410A2 G protein-coupled receptors
11/01/2001	WO2001081408A2 G-protein coupled receptor (gpcr) agonists and antagonists and methods of activating and inhibiting gpcr using the same
11/01/2001	WO2001081405A2 Methods and compositions for the prevention and treatment of anemia
11/01/2001	WO2001081402A1 Tnfr related gene 12
11/01/2001	WO2001081399A1 A novel polypeptide, a human pax protein 14 and the polynucleotide encoding the polypeptide
11/01/2001	WO2001081398A1 A novel polypeptide, a human pax protein 16 and the polynucleotide encoding the polypeptide
11/01/2001	WO2001081397A1 A novel polypeptide, a translation initiation factor human cofactor 81 and the polynucleotide encoding the polypeptide
11/01/2001	WO2001081396A1 A new polypeptide - human ribosomal s7 protein 14 and the polynucleotide encoding it
11/01/2001	WO2001081392A1 A novel polypeptide, human nucleolar phosphoprotein 13 and the polynucleotide encoding thereof
11/01/2001	WO2001081391A1 A novel polypeptide, a protein 29 similar to g beta and the polynucleotide encoding the polypeptide
11/01/2001	WO2001081389A1 A novel polypeptide, human protein 9 comprising the characteristic fragment of ribosomal protein l19 and the polynucleotide encoding thereof
11/01/2001	WO2001081387A1 Human cervical cancer suppressor protein, polynucleotide encoding the protein, cell transformed with the polynucleotide and method for suppressing proliferation of cancer cell using the expression vector
11/01/2001	WO2001081386A1 A novel polypeptide - human pax protein 12.5 and the polynucleotide encoding said polypeptide
11/01/2001	WO2001081385A1 A novel polypeptide, a human reductase nucleotide 9 and the polynucleotide encoding the polypeptide
11/01/2001	WO2001081384A1 A novel polypeptide-laminin 16 and the polynucleotide encoding said polypeptide
11/01/2001	WO2001081383A1 A novel polypeptide-homo phosphatase 9 and polynucleotide encoding said polypeptide
11/01/2001	WO2001081382A1 A novel polypeptide-homo hs1 protein 16 and polynucleotide encoding said polypeptide
11/01/2001	WO2001081381A1 A novel polypeptide, a human protein 11 containing site-specific recombinase characteristic sequence fragment and the polynucleotide encoding the polypeptide
11/01/2001	WO2001081378A2 G-protein coupled receptors
11/01/2001	WO2001081377A2 Integrin/adhesion antagonists
11/01/2001	WO2001081376A2 Apo-ai/aii peptide derivatives
11/01/2001	WO2001081373A2 Glycopeptide antibacterial compounds and methods of using same
11/01/2001	WO2001081372A2 Vancomycin analogs
11/01/2001	WO2001081371A1 Gd3-mimetic peptides
11/01/2001	WO2001081368A2 Blood-pressure reducing polypeptides containing vpp derived from microorganisms
11/01/2001	WO2001081366A2 Purification of ace inhibiting polypeptides containing vpp from milk
11/01/2001	WO2001081363A1 Novel compounds
11/01/2001	WO2001081361A1 Compositions and method for diagnosing and treating conditions, disorders, or diseases involving cell death
11/01/2001	WO2001081325A2 Macrocyclic ns3-serine protease inhibitors of hepatitis c virus comprising alkyl and aryl alanine p2 moieties
11/01/2001	WO2001080897A2 Compositions and methods for in vivo delivery of polynucleotide-based therapeutics
11/01/2001	WO2001080891A1 Remedies for interstitial pneumonia, method of constructing animal model of this disease and screening method with the use of the same
11/01/2001	WO2001080889A1 Product and process for regulation of t cell responses
11/01/2001	WO2001080887A2 Methods and chemokin compositions for inducing an immune response
11/01/2001	WO2001080884A1 Intrathecal administration of rituximab for treatment of central nervous system lymphomas
11/01/2001	WO2001080883A1 Bispecific molecules and uses thereof
11/01/2001	WO2001080882A2 Methods and compositions for eliciting an immune response
11/01/2001	WO2001080878A1 Use of recombinant gastric lipase for treating functional dyspepsia
11/01/2001	WO2001080877A1 Preventives for reinfection after liver transplantation
11/01/2001	WO2001080876A1 Utilization of adamts-1 protein and method of screening aggrecanase activity regulator
11/01/2001	WO2001080875A1 A memory enhancing protein
11/01/2001	WO2001080873A2 Thrombopoietin receptor modulating peptide
11/01/2001	WO2001080872A1 Method of binding integrin for treatment of cancer
11/01/2001	WO2001080871A2 Use of guanylate cyclase-c (gc-c) agonists as insulinotropic factors for treating diabetes type 2
11/01/2001	WO2001080864A2 Chemical modification of mammalian urine and blood
11/01/2001	WO2001080849A1 Method of treating cancer
11/01/2001	WO2001080836A1 Use of particulate vectors in immunomodulation
11/01/2001	WO2001080832A2 Administration of a thiol-based chemoprotectant compound
11/01/2001	WO2001080830A2 Pharmacotherapeutic process and composition for central nervous system disorders
11/01/2001	WO2001080829A2 Taste masking coating composition
11/01/2001	WO2001080817A1 Dextranase-containing oral care compositions
11/01/2001	WO2001080811A2 Mmp-2 propeptide for use as antiangiogenic or antitumor agent
11/01/2001	WO2001080633A2 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema

1 ... 2170 2171 2172 2173 2174 2175 2176 2177 2178 2179 2180 2181 2182 2183 2184 2185 2186 2187 2188 2189 2190 ... 3163